Chemours Co Stock Filter Stocks by Fundamentals
CC Stock | USD 28.88 1.51 5.52% |
Chemours Co fundamentals help investors to digest information that contributes to Chemours' financial success or failures. It also enables traders to predict the movement of Chemours Stock. The fundamental analysis module provides a way to measure Chemours' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chemours stock.
Chemours | Number of Shares Shorted |
Chemours Number of Shares Shorted Analysis
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.4B | 1.6B | 1.5B | 1.2B | Total Revenue | 6.3B | 6.8B | 6.1B | 5.1B |
Chemours Number of Shares Shorted Driver Correlations
Understanding the fundamental principles of building solid financial models for Chemours is extremely important. It helps to project a fair market value of Chemours Stock properly, considering its historical fundamentals such as Number of Shares Shorted. Since Chemours' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Chemours' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Chemours' interrelated accounts and indicators.
Click cells to compare fundamentals
Competition |
Based on the recorded statements, Chemours Co has 0.0null of outstending shares currently sold short by investors. This indicator is about the same for the Chemicals average (which is currently at 0.0) sector and about the same as Number of Shares Shorted (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
All Next | Launch Module |
Chemours Fundamentals
Return On Equity | -0.3 | ||||
Return On Asset | -0.0074 | ||||
Profit Margin | (0.05) % | ||||
Operating Margin | 0.06 % | ||||
Current Valuation | 7.44 B | ||||
Shares Outstanding | 148.44 M | ||||
Shares Owned By Insiders | 0.78 % | ||||
Shares Owned By Institutions | 77.54 % | ||||
Number Of Shares Shorted | 4.71 M | ||||
Price To Earning | 25.49 X | ||||
Price To Book | 5.38 X | ||||
Price To Sales | 0.71 X | ||||
Revenue | 6.79 B | ||||
Gross Profit | 1.62 B | ||||
EBITDA | 1.2 B | ||||
Net Income | 578 M | ||||
Cash And Equivalents | 1.1 B | ||||
Cash Per Share | 7.73 X | ||||
Total Debt | 3.81 B | ||||
Debt To Equity | 2.94 % | ||||
Current Ratio | 1.82 X | ||||
Book Value Per Share | 5.09 X | ||||
Cash Flow From Operations | 754 M | ||||
Short Ratio | 2.01 X | ||||
Earnings Per Share | (2.00) X | ||||
Price To Earnings To Growth | 1.67 X | ||||
Target Price | 29.22 | ||||
Number Of Employees | 6.6 K | ||||
Beta | 1.97 | ||||
Market Capitalization | 4.25 B | ||||
Total Asset | 7.64 B | ||||
Retained Earnings | 2.17 B | ||||
Working Capital | 1.32 B | ||||
Current Asset | 2.3 B | ||||
Current Liabilities | 1.47 B | ||||
Z Score | 2.68 | ||||
Annual Yield | 0.04 % | ||||
Five Year Return | 3.59 % | ||||
Net Asset | 7.64 B | ||||
Last Dividend Paid | 1.0 |
About Chemours Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chemours Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chemours using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chemours Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware. Chemours operates under Specialty Chemicals classification in the United States and is traded on New York Stock Exchange. It employs 6400 people.
Pair Trading with Chemours
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemours position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will appreciate offsetting losses from the drop in the long position's value.Moving against Chemours Stock
0.66 | DNMR | Danimer Scientific Earnings Call Today | PairCorr |
0.6 | ASH | Ashland Global Holdings Financial Report 7th of May 2024 | PairCorr |
0.55 | NTIC | Northern Technologies Report 11th of April 2024 | PairCorr |
0.51 | WTTR | Select Energy Services Financial Report 7th of May 2024 | PairCorr |
The ability to find closely correlated positions to Chemours could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemours when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemours - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemours Co to buy it.
The correlation of Chemours is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemours moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemours moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chemours can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Chemours Piotroski F Score and Chemours Altman Z Score analysis. Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.91) | Dividend Share 1 | Earnings Share (2.00) | Revenue Per Share 40.243 | Quarterly Revenue Growth (0.16) |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.